Low
₹277.05
High
₹293.40
| Previous Close | ₹288.55 |
|---|---|
| Day's Range | ₹277.05 - ₹293.40 |
| Open | ₹279.75 |
| 52 Week Range | ₹272.35 - ₹608.90 |
| Volume | 3,99,535 |
| Market Cap | ₹0.00 |
| Previous Close | ₹289.00 |
|---|---|
| Day's Range | ₹277.20 - ₹293.95 |
| Open | ₹280.00 |
| 52 Week Range | ₹272.45 - ₹608.60 |
| Volume | 16,142 |
| Market Cap | ₹0.00 |
| Trade Value ( ₹ in Lacs) | 1,152.86 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.55 |
| Price/Earning (TTM) | 43.43 |
| TTM EPS (₹) | 6.33 |
| P/E Ratio | 49.42 |
| Book Value(₹) | 1.74 |
| PAT Margin (%) | 7.91 |
| Face Value (₹) | 5.00 |
| ROCE(%) | 11.40 |
| Trade Value ( ₹ in Lacs) | 46.65 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.55 |
| Price/Earning (TTM) | 43.43 |
| TTM EPS (₹) | 6.33 |
| P/E Ratio | 49.42 |
| Book Value(₹) | 1.74 |
| PAT Margin (%) | 7.91 |
| Face Value (₹) | 5.00 |
| ROCE(%) | 11.40 |
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 5426.02 | 1544.72 |
| Expenses | N/A | N/A |
| PBT | 460.08 | 117.22 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 394.96 | 111.78 |
| Founded | 1993 |
|---|---|
| Managing Director | Sajankumar Rameshwarlal Bajaj |
| NSE Symbol | BAJAJHCARE |
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,57,121.30 | 1,882.15 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,81,396.01 | 6,919.65 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,48,729.85 | 4,457.15 | 3,102.00 - 3,102.00 |
| Apollo Hospitals Enterprise Ltd. | 1,15,331.11 | 8,026.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,15,240.83 | 1,410.00 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,11,126.23 | 1,333.95 | 1,148.40 - 1,148.40 |
| Mankind Pharma Ltd. | 1,03,056.40 | 2,477.50 | 1,909.70 - 1,909.70 |
| Max Healthcare Institute Ltd. | 1,03,022.72 | 1,063.55 | 903.00 - 903.00 |
| Lupin Ltd. | 1,03,010.73 | 2,286.50 | 1,836.80 - 1,836.80 |
| Zydus Lifesciences Ltd. | 99,737.91 | 1,018.95 | 835.50 - 835.50 |
No Records Found
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Bajaj Healthcare has informed that the Company has signed Deed of Assignment and Transfer with Bethany Pharmacare on March 17, 2026 for the sale of an undertaking of the Company situated at Plot No. L-9/3, MIDC, Tarapur, Taluka Boisar, District Palghar, Maharashtra. Further, the company has confirmed that none of the promoter/ promoter group/ group companies have any interest in the aforesaid entity and the transaction does not fall within the purview of related party transactions. The brief details, in accordance with the SEBI Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed as ‘Annexure-I’.
The above information is a part of company’s filings submitted to BSE.
Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bajaj Healthcare has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, March 18, 2026, to consider and approve the allotment of Equity Shares to the Promoter, Promoter Group and Person(s) belonging to the Non-Promoter Public Category, pursuant to the exercise of options for conversion of Convertible Warrants into Equity Shares, which were allotted on a Preferential basis on September 19, 2024.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The current share price of Bajaj Healthcare Ltd. is ₹288.55 as of 2026-05-19.
The market capitalisation of Bajaj Healthcare Ltd. is ₹925.55 as of 2026-05-18.
The 1-year return of Bajaj Healthcare Ltd. is 13.60% as of 2026-05-19.
The P/E ratio of Bajaj Healthcare Ltd. is 49.42 as of 2026-05-19.
The 52-week high and low of Bajaj Healthcare Ltd. are ₹608.90 and ₹272.35, respectively, as of 2026-05-19.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.